An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial ...

Breakthrough research shows diabetes medicine metformin may reduce age-related vision loss by 37%. Liverpool study offers ...

TUPELO – Usage of GLP-1 drugs isn't new – they gained FDA approval in 2005, and evolved from 1980s diabetes research. But ...

A group of medications often used to treat diabetes may also help protect aging kidneys, according to a new study.

Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new ...

The Trump administration's new discounted drug platform isn't a game-changer for consumers, health care experts said.

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc lowered cholesterol, blood fats, and artery-clogging plaques while calming ...

In patients with diabetes, sustained use of GLP-1 receptor agonists is associated with a modestly higher risk for new-onset ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

President Donald Trump last week launched a new prescription discount platform called TrumpRx, offering 43 medications at ...

Eli Lilly announced an acquisition of an innovative new autoimmune drug.

Feb 2 (Reuters) - Novo Nordisk said on Monday its experimental next-generation weight-loss drug CagriSema showed greater ...